Task 4: The Interventional Agent Development Services program

任务 4：介入药物开发服务计划

• 批准号: 8907828
• 负责人: Jon Carl Mirsalis
• 金额: $ 43.03万
• 依托单位: SRI INTERNATIONAL
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-20 至 2015-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8907828
• 关键词: Clostridium difficile; Communicable Diseases; Contracts; Development; National Institute of Allergy and Infectious Disease; Safety; Services; Toxicology; pre-clinical; programs; therapeutic development

This contract provides for preclinical microbiological, safety, toxicology and biokenetics services under the NIAID Preclinical Services for the Development of Interventional Agents Program for infectious diseases.

该合同规定 NIAID 传染病干预药物开发临床前服务项目下的临床前微生物学、安全性、毒理学和生物动力学服务。